17-7592748-C-G
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_004860.4(FXR2):āc.1675G>Cā(p.Val559Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000235 in 1,613,682 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_004860.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
FXR2 | NM_004860.4 | c.1675G>C | p.Val559Leu | missense_variant | 14/17 | ENST00000250113.12 | |
FXR2 | XM_047437106.1 | c.1675G>C | p.Val559Leu | missense_variant | 14/17 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
FXR2 | ENST00000250113.12 | c.1675G>C | p.Val559Leu | missense_variant | 14/17 | 1 | NM_004860.4 | P1 | |
FXR2 | ENST00000704984.1 | c.1894G>C | p.Val632Leu | missense_variant | 14/17 | ||||
MPDU1 | ENST00000423172.6 | c.*276C>G | 3_prime_UTR_variant | 6/6 | 2 |
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 151992Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000402 AC: 1AN: 248772Hom.: 0 AF XY: 0.00000741 AC XY: 1AN XY: 134994
GnomAD4 exome AF: 0.0000253 AC: 37AN: 1461690Hom.: 0 Cov.: 32 AF XY: 0.0000261 AC XY: 19AN XY: 727120
GnomAD4 genome AF: 0.00000658 AC: 1AN: 151992Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74230
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 24, 2024 | The c.1675G>C (p.V559L) alteration is located in exon 14 (coding exon 14) of the FXR2 gene. This alteration results from a G to C substitution at nucleotide position 1675, causing the valine (V) at amino acid position 559 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at